Claritev Corporation reports Q3 2025 revenue of $246 million and net loss of $69.8 million

Reuters

Nov 07

<a href="https://laohu8.com/S/CTEV">Claritev Corporation</a> reports Q3 2025 revenue of $246 million and net loss of $69.8 million

Claritev Corporation reported third quarter 2025 revenues of $246.0 million, a 6.7% increase compared to the same period in 2024. Adjusted EBITDA for the quarter was $155.1 million, up 9.5% year-over-year, with an Adjusted EBITDA margin of 63.1% versus 61.5% in the prior year quarter. The company reported a net loss of $69.8 million for the period. Claritev raised its full-year 2025 revenue and Adjusted EBITDA guidance. Total current assets as of September 30, 2025, were $257.5 million, and total shareholders' deficit was $101.8 million, compared to shareholders' equity of $84.0 million at the end of 2024. Key business developments included a focus on making healthcare more affordable, transparent, and fair.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief on November 07, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2581091780"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2581091780\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2581091780?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 19:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581091780","market":"us","top_or_hot":-1,"title":"Claritev Corporation reports Q3 2025 revenue of $246 million and net loss of $69.8 million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/CTEV\">Claritev Corporation</a> reports Q3 2025 revenue of $246 million and net loss of $69.8 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/MPLNW\">Claritev Corporation</a> reported third quarter 2025 revenues of $246.0 million, a 6.7% increase compared to the same period in 2024. Adjusted EBITDA for the quarter was $155.1 million, up 9.5% year-over-year, with an Adjusted EBITDA margin of 63.1% versus 61.5% in the prior year quarter. The company reported a net loss of $69.8 million for the period. Claritev raised its full-year 2025 revenue and Adjusted EBITDA guidance. Total current assets as of September 30, 2025, were $257.5 million, and total shareholders' deficit was $101.8 million, compared to shareholders' equity of $84.0 million at the end of 2024. Key business developments included a focus on making healthcare more affordable, transparent, and fair.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief on November 07, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Claritev Corporation reports Q3 2025 revenue of $246 million and net loss of $69.8 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClaritev Corporation reports Q3 2025 revenue of $246 million and net loss of $69.8 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-07 19:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/CTEV\">Claritev Corporation</a> reports Q3 2025 revenue of $246 million and net loss of $69.8 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/MPLNW\">Claritev Corporation</a> reported third quarter 2025 revenues of $246.0 million, a 6.7% increase compared to the same period in 2024. Adjusted EBITDA for the quarter was $155.1 million, up 9.5% year-over-year, with an Adjusted EBITDA margin of 63.1% versus 61.5% in the prior year quarter. The company reported a net loss of $69.8 million for the period. Claritev raised its full-year 2025 revenue and Adjusted EBITDA guidance. Total current assets as of September 30, 2025, were $257.5 million, and total shareholders' deficit was $101.8 million, compared to shareholders' equity of $84.0 million at the end of 2024. Key business developments included a focus on making healthcare more affordable, transparent, and fair.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief on November 07, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CTEV","symbol_name":"Claritev Corporation","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL56VQjT:1","article_id":"2581091780","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581091780","pubTimestamp":1762513287,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Claritev Corporation reported third quarter 2025 revenues of $246.0 million, a 6.7% increase compared to the same period in 2024. Adjusted EBITDA for the quarter was $155.1 million, up 9.5% year-over-year, with an Adjusted EBITDA margin of 63.1% versus 61.5% in the prior year quarter. The company reported a net loss of $69.8 million for the period. Claritev raised its full-year 2025 revenue and Adjusted EBITDA guidance. Total current assets as of September 30, 2025, were $257.5 million, and total shareholders' deficit was $101.8 million, compared to shareholders' equity of $84.0 million at the end of 2024. Key business developments included a focus on making healthcare more affordable, transparent, and fair.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investmen","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CTEV":"Claritev Corporation","BK4167":"医疗保健技术"},"translate_title":"Claritev Corporation报告2025年第三季度收入为2.46亿美元，净亏损为6980万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CTEV":0.9},"content_text":"Claritev Corporation reports Q3 2025 revenue of $246 million and net loss of $69.8 million\n    \n\nClaritev Corporation reported third quarter 2025 revenues of $246.0 million, a 6.7% increase compared to the same period in 2024. Adjusted EBITDA for the quarter was $155.1 million, up 9.5% year-over-year, with an Adjusted EBITDA margin of 63.1% versus 61.5% in the prior year quarter. The company reported a net loss of $69.8 million for the period. Claritev raised its full-year 2025 revenue and Adjusted EBITDA guidance. Total current assets as of September 30, 2025, were $257.5 million, and total shareholders' deficit was $101.8 million, compared to shareholders' equity of $84.0 million at the end of 2024. Key business developments included a focus on making healthcare more affordable, transparent, and fair.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief on November 07, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}